BR112012028766A2 - processo para a preparação de complexos de insulina e zinco - Google Patents

processo para a preparação de complexos de insulina e zinco

Info

Publication number
BR112012028766A2
BR112012028766A2 BR112012028766A BR112012028766A BR112012028766A2 BR 112012028766 A2 BR112012028766 A2 BR 112012028766A2 BR 112012028766 A BR112012028766 A BR 112012028766A BR 112012028766 A BR112012028766 A BR 112012028766A BR 112012028766 A2 BR112012028766 A2 BR 112012028766A2
Authority
BR
Brazil
Prior art keywords
insulin
preparation
zinc complexes
solution
insulin derivative
Prior art date
Application number
BR112012028766A
Other languages
English (en)
Inventor
Andresen Lene
Jeppesen Per
Rebecca Erritzoe Hansen Rosa
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR112012028766A2 publication Critical patent/BR112012028766A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

processo para a preparação de complexos de insulina e zinco. a presente invenção refere-se a um processo para preparar uma formulação farmacêutica compreendendo um derivado de insulina, em que o processo compreende dissolver um derivado de insulina em água, ajustar o ph da solução até um ph acima de 7,2, adicionar uma solução de zinco enquanto agita continuamente e ajustar o ph até o ph alvo da formulação.
BR112012028766A 2010-05-10 2011-05-09 processo para a preparação de complexos de insulina e zinco BR112012028766A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10162368 2010-05-10
US33349710P 2010-05-11 2010-05-11
PCT/EP2011/057388 WO2011141407A1 (en) 2010-05-10 2011-05-09 Process for the preparation of insulin-zinc complexes

Publications (1)

Publication Number Publication Date
BR112012028766A2 true BR112012028766A2 (pt) 2017-06-13

Family

ID=42732779

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012028766A BR112012028766A2 (pt) 2010-05-10 2011-05-09 processo para a preparação de complexos de insulina e zinco

Country Status (12)

Country Link
US (4) US20130143803A1 (pt)
EP (1) EP2569002B1 (pt)
JP (2) JP6249773B2 (pt)
KR (2) KR20130092972A (pt)
CN (2) CN107029212A (pt)
AU (1) AU2011252127B2 (pt)
BR (1) BR112012028766A2 (pt)
CA (1) CA2795091A1 (pt)
ES (1) ES2612468T3 (pt)
MX (1) MX2012012943A (pt)
RU (1) RU2572214C2 (pt)
WO (1) WO2011141407A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006082204A1 (en) 2005-02-02 2006-08-10 Novo Nordisk A/S Insulin derivatives
EP2505593A1 (en) 2005-12-28 2012-10-03 Novo Nordisk A/S Compositions comprising an acylated insulin and zinc and method of making the said compositions
ATE482977T1 (de) 2006-02-27 2010-10-15 Novo Nordisk As Insulinderivate
KR101441444B1 (ko) * 2006-05-09 2014-09-18 노보 노르디스크 에이/에스 인슐린 유도체
US8796205B2 (en) 2006-05-09 2014-08-05 Novo Nordisk A/S Insulin derivative
WO2008152106A1 (en) 2007-06-13 2008-12-18 Novo Nordisk A/S Pharmaceutical formulation comprising an insulin derivative
US8710000B2 (en) 2007-11-08 2014-04-29 Novo Nordisk A/S Insulin derivative
ES2607003T3 (es) 2008-10-30 2017-03-28 Novo Nordisk A/S Tratamiento de diabetes mellitus utilizando inyecciones de insulina con una frecuencia de inyección inferior a la diaria
RU2013123515A (ru) 2010-10-27 2014-12-10 Ново Нордиск А/С Лечение сахарного диабета с помощью инъекций инсулина, вводимых с различными интервалами
JP6755175B2 (ja) * 2013-03-20 2020-09-16 ノヴォ ノルディスク アー／エス インスリン投薬レジメン
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
AU2014333979B2 (en) * 2013-10-07 2018-02-15 Novo Nordisk A/S Novel derivative of an insulin analogue
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
EP3006045B3 (en) 2014-10-07 2021-03-17 Cyprumed GmbH Pharmaceutical formulations for the oral delivery of peptide or protein drugs
EP3740195A1 (fr) * 2017-12-07 2020-11-25 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
TWI740099B (zh) * 2018-02-01 2021-09-21 大陸商江蘇恒瑞醫藥股份有限公司 含人胰島素類似物的醯化衍生物的藥物組合物及其製備方法
BR112020023485A2 (pt) 2018-05-24 2021-03-30 Jiangsu Hengrui Medicine Co., Ltd. Métodos para preparar um precursor de insulina humana recombinante ou análogo da mesma, insulina humana recombinante ou análogo da mesma e análogo de insulina acilado
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
AU2019398402A1 (en) 2018-12-11 2021-07-29 Sanofi Insulin analogs having reduced insulin receptor binding affinity

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1212679B (de) * 1957-08-03 1966-03-17 Novo Terapeutisk Labor As Verfahren zur Herstellung von Insulinloesungen
GB1042194A (en) * 1962-04-30 1966-09-14 Olin Mathieson Insulin preparations
US3868358A (en) * 1971-04-30 1975-02-25 Lilly Co Eli Protamine-insulin product
DK113585D0 (da) * 1985-03-12 1985-03-12 Novo Industri As Nye peptider
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
KR910700262A (ko) 1988-12-23 1991-03-14 안네 제케르 사람 인슐린 유사체
NZ232375A (en) 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
ATE204882T1 (de) * 1993-09-17 2001-09-15 Novo Nordisk As Acyliertes insulin
US7097845B2 (en) * 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
PT2107069E (pt) * 2003-08-05 2013-04-23 Novo Nordisk As Novos derivados de insulina
BRPI0413276B8 (pt) 2003-08-05 2021-05-25 Novo Nordisk As derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica
EP2505593A1 (en) * 2005-12-28 2012-10-03 Novo Nordisk A/S Compositions comprising an acylated insulin and zinc and method of making the said compositions
WO2008152106A1 (en) * 2007-06-13 2008-12-18 Novo Nordisk A/S Pharmaceutical formulation comprising an insulin derivative
TWI451876B (zh) * 2008-06-13 2014-09-11 Lilly Co Eli 聚乙二醇化之離脯胰島素化合物

Also Published As

Publication number Publication date
CA2795091A1 (en) 2011-11-17
AU2011252127A1 (en) 2012-11-01
RU2572214C2 (ru) 2015-12-27
AU2011252127B2 (en) 2014-02-20
EP2569002B1 (en) 2016-10-26
JP6249773B2 (ja) 2017-12-20
KR20160105979A (ko) 2016-09-08
JP2013526501A (ja) 2013-06-24
EP2569002A1 (en) 2013-03-20
ES2612468T3 (es) 2017-05-17
US20130143803A1 (en) 2013-06-06
WO2011141407A1 (en) 2011-11-17
RU2012148821A (ru) 2014-06-20
CN102883743A (zh) 2013-01-16
CN107029212A (zh) 2017-08-11
US20210060132A1 (en) 2021-03-04
MX2012012943A (es) 2012-11-29
JP2017203042A (ja) 2017-11-16
US20150250857A1 (en) 2015-09-10
KR20130092972A (ko) 2013-08-21
US20170165327A1 (en) 2017-06-15

Similar Documents

Publication Publication Date Title
BR112012028766A2 (pt) processo para a preparação de complexos de insulina e zinco
MY160249A (en) Fatty acid fumarate derivatives and their uses
NZ613807A (en) Phosphorus-containing group-substituted quinoline, its preparation process, medical composition containing the compound and application
BR112015005940A2 (pt) processo para a preparação de nanopartículas terapêuticas
NZ732777A (en) Ionizable cationic lipid for rna delivery
CU20130137A7 (es) Derivados de ácido 3- fenilpropiónico ramificados y su uso
EA201201648A1 (ru) Стимуляторы sgc
AR081060A1 (es) Procedimiento para preparar 4-{4-[({[4-cloro-3-(trifluorometil)fenil]amino}carbonil)amino]-3-fluorofenoxi}-n-metilpiridin-2-carboxamida
BR112013000675A2 (pt) nanopartícula, processo para produzir uma nanopartícula compreendendo uma matriz de zeína e um aminoácido básico, processo para produzir uma nanopartícula compreendendo uma matriz de zeína, e um aminoácido básico e um composto biologicamente ativo solúvel em gordura, composição e produto alimentar
MX357780B (es) Derivados policíclicos, proceso para su preparación y su uso farmacéutico.
BRPI0918360A8 (pt) Composto, composição farmacêutica e usos de um composto
UY33776A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
BRPI0908421B8 (pt) solução estável de um composto farmacêutico
IN2015DN00137A (pt)
BR112015028278A2 (pt) processo para a preparação de eritrócitos carregados com uma ou mais substâncias de interesse farmacêutico e eritrócitos assim obtidos
BR112013000776A2 (pt) método e formulação para tratamento de deficiência de ácido siálico
AU2012245910A8 (en) Microfluidic system for controlling the concentration of molecules for stimulating a target
MY184277A (en) Formulations of deoxyccholic acid and salts thereof
BR112013001301A2 (pt) processo para preparar uma composição líquida farmacêutica compreendendo imunoglobulina g humana e composição líquida farmacêutica contendo imunoglobulina g humana
MX2016011290A (es) Composiciones de ester de colina de acido lipoico y metodos de uso.
BR112012014151A2 (pt) "produto de proteína e processo para a preparação de um produto de proteína injetável"
BR112012017994B8 (pt) composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio
TN2015000498A1 (en) Modified release formulation
BR112013018738A2 (pt) novos derivados de tetrahidroquinolina
EP4282972A3 (en) Production of branched chain fatty acids and derivatives thereof in recombinant microbial cells

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal: dismissal of application maintained
B350 Update of information on the portal [chapter 15.35 patent gazette]